Dose escalation for non-small cell lung cancer: Analysis and modelling of published literature

Radiotherapy and Oncology

Volumn 99, Issue 1, 2011, Pages 6-11

  Partridge, Mike ^a   Ramos, Mónica ^b   Sardaro, Angela ^b   Brada, Michael ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Dose response; External beam radiotherapy; Non small cell lung cancer

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOSIMETRY; ESOPHAGUS DISEASE; ESOPHAGUS TOXICITY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW; SYSTEMATIC REVIEW; TOXICITY; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGUS; HUMANS; LUNG; LUNG NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 79954598436     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.02.014     Document Type: Review

References (33)

1. M. Hoyer, H. Roed, and A.T. Hansen Prospective study on stereotactic radiotherapy of limited stage non-small cell lung cancer I J Radiat Oncol Biol Phys 63 2005 S396
2. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631 (Pubitemid 39318910)
3. J.J. Beitler, E.A. Badine, and D. El-Sayah Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years Int J Radiat Oncol Biol Phys 65 2006 100 106
4. M. Uematsu, A. Shioda, and A. Suda Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience Int J Radiat Oncol Biol Phys 51 2001 666 670
5. J.G. Armstrong, M.J. Zelefsky, and S.A. Leibel Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer Ann Oncol 6 1995 693 697
6. M. Saunders, S. Dische, A. Barrett, A. Harvey, D. Gibson, and M. Parmar Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial CHART Steering Committee. Lancet 350 1997 161 165 (Pubitemid 27303621)
7. S. Sim, K.E. Rosenzweig, R. Schindelheim, K.K. Ng, and S.A. Leibel Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 51 2001 660 665
8. J.A. Hayman, M.K. Martel, and R.K. Ten Haken Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial J Clin Oncol 19 2001 127 136 (Pubitemid 32063489)
9. J.G. Rosenman, J.S. Halle, and M.A. Socinski High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356 (Pubitemid 35286797)
10. K.L. Wu, G.L. Jiang, and Y. Liao Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial Int J Radiat Oncol Biol Phys 57 2003 1336 1344 (Pubitemid 37443974)
11. P. Thirion, O. Holmberg, and C.D. Collins Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy Radiother Oncol 71 2004 163 166 (Pubitemid 38521184)
12. S. Narayan, G.T. Henning, R.K. Ten Haken, M.A. Sullivan, M.K. Martel, and J.A. Hayman Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer Lung cancer 44 2004 79 88 (Pubitemid 38317264)
13. F.M. Kong, R.K. Ten Haken, and M.J. Schipper High-dose radiation improved local tumor control and overall survival in patients with inoperable/ unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study Int J Radiat Oncol Biol Phys 63 2005 324 333 (Pubitemid 41317147)
14. J. Bradley, M.V. Graham, and K. Winter Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318 328 (Pubitemid 40164423)
15. J.S. Belderbos, W.D. Heemsbergen, K. De Jaeger, P. Baas, and J.V. Lebesque Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy Int J Radiat Oncol Biol Phys 66 2006 126 134 (Pubitemid 44175671)
16. F.M. Kong, J.A. Hayman, and K.A. Griffith Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis Int J Radiat Oncol Biol Phys 65 2006 1075 1086 (Pubitemid 44202245)
17. S.L. Faria, L. Souhami, and L. Portelance Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer Radiat Oncol 1 2006 42
18. D. De Ruysscher, R. Wanders, and E. van Haren HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 71 2008 132 138 (Pubitemid 351491406)
19. S. Fukumoto, H. Shirato, and S. Shimzu Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas Cancer 95 2002 1546 1553
20. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431 (Pubitemid 41628038)
21. R. Onimaru, H. Shirato, and S. Shimizu Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 56 2003 126 135 (Pubitemid 36403684)
22. J. Wulf, U. Haedinger, U. Oppitz, W. Thiele, G. Mueller, and M. Flentje Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients Int J Radiat Oncol Biol Phys 60 2004 186 196 (Pubitemid 39165484)
23. T. Xia, H. Li, and Q. Sun Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer Int J Radiat Oncol Biol Phys 66 2006 117 125 (Pubitemid 44175645)
24. R. Timmerman, L. Papiez, and R. McGarry Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955 (Pubitemid 37433596)
25. B.D. Kavanagh, R.D. Timmerman, and S.H. Benedict How should we describe the radioblologic effect of extracranial stereotactic radlosurgery: equivalent uniform dose or tumor control probability? Med Phys 30 2003 321 324 (Pubitemid 36337097)
26. R.G. Dale, and B. Jones Radiogiological modelling in radiation oncology 2007 British Institute of Radiology London
27. A. van Baardwijk, G. Bosmans, and S.M. Bentzen Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial Int J Radiat Oncol Biol Phys 71 2008 1103 1110
28. T. Naruke, R. Tsuchiya, H. Kondo, H. Asamura, and H. Nakayama Implications of staging in lung cancer Chest 112 1997 242S 248S (Pubitemid 27441089)
29. J.D. Fenwick, A.E. Nahum, and Z.I. Malik Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement Clin Oncol (R Coll Radiol) 2009
30. M.K. Martel, R.K. Ten Haken, and M.B. Hazuka Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients Lung Cancer 24 1999 31 37 (Pubitemid 29241815)
31. M. Stuschke, and C. Pöttgen Altered fractionation schemes in radiotherapy Front Radiat Ther Oncol 42 2010 150 156
32. M. Partridge, A. Tree, and J. Brock Improving tumour control probability with active breathing control and dose escalation Clin Oncol 21 2009 250
33. N. Panakis, H.A. McNair, and J.A. Christian Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters Radiother Oncol 87 2008 65 73